Vanda Pharmaceuticals to Announce Fourth Quarter 2014 Financial Results on February 19, 2015

WASHINGTON, Feb. 2, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) VNDA, a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the fourth quarter of 2014 on Thursday, February 19, 2015, before the market opens.

The Company will host a conference call at 10:00 AM ET on Thursday, February 19, 2015, during which Vanda management will discuss the fourth quarter and full year 2014 financial results and other corporate activities. To participate in the conference call, please dial 1-800-708-4540 (domestic) or 1-847-619-6397 (international) and use passcode 38933858.

The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com.  Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Thursday, February 19, 2015, beginning at 12:30 PM ET and will be accessible until Thursday, February 26, 2015, at 11:59 PM ET.  The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 38933858.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Jim Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-fourth-quarter-2014-financial-results-on-february-19-2015-300029569.html

SOURCE Vanda Pharmaceuticals Inc.